Effect of rituximab on a salivary gland ultrasound score in primary Sjögren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy.

MLA

Fisher, Benjamin A., et al. “Effect of Rituximab on a Salivary Gland Ultrasound Score in Primary Sjögren’s Syndrome: Results of the TRACTISS Randomised Double-Blind Multicentre Substudy.” Annals of the Rheumatic Diseases, vol. 77, no. 3, Mar. 2018, pp. 412–16. EBSCOhost, https://doi.org/10.1136/annrheumdis-2017-212268.

APA

Fisher, B. A., Everett, C. C., Rout, J., O’Dwyer, J. L., Emery, P., Pitzalis, C., Wan-Fai Ng, Carr, A., Pease, C. T., Price, E. J., Sutcliffe, N., Makdissi, J., Tappuni, A. R., Gendi, N. S. T., Hall, F. C., Ruddock, S. P., Fernandez, C., Hulme, C. T., Davies, K. A., & Edwards, C. J. (2018). Effect of rituximab on a salivary gland ultrasound score in primary Sjögren’s syndrome: results of the TRACTISS randomised double-blind multicentre substudy. Annals of the Rheumatic Diseases, 77(3), 412–416. https://doi.org/10.1136/annrheumdis-2017-212268

Chicago

Fisher, Benjamin A., Colin C. Everett, John Rout, John L. O’Dwyer, Paul Emery, Costantino Pitzalis, Wan-Fai Ng, et al. 2018. “Effect of Rituximab on a Salivary Gland Ultrasound Score in Primary Sjögren’s Syndrome: Results of the TRACTISS Randomised Double-Blind Multicentre Substudy.” Annals of the Rheumatic Diseases 77 (3): 412–16. doi:10.1136/annrheumdis-2017-212268.